OPINION

CHRIS LANCELOT

Opinions

Showing 1 - 10 of 91 Articles
 

When it comes to IT, the NHS is in the Stone Age

by Chris Lancelot

24-Jul-08 09:00

The National Programme for IT (NPfIT) is now four years behind schedule and will cost £300 million m... Read more

Shredding the administrative paper trail

by Chris Lancelot

26-Jun-08 00:00

In all the doom and gloom of our chaotic NHS, it really is good once in a while to be able to report... Read more

Save the NHS from decay with a simple KISS

by Chris Lancelot

20-Jun-08 00:00

Parkinson's third law says 'Growth leads to complexity, complexity to decay'. It couldn't describe t... Read more

How so little improvement costs us so much

13-Jun-08 00:00

The NHS is approaching its 60th birthday and Lord Darzi is about to publish his review, so I thought... Read more

Desperate measurers fear a truly free market

by Chris Lancelot

28-May-08 00:00

One of the least-recognised attributes of a truly free market is that it contains a lot of informati... Read more

The NHS can learn a lot from Milton Friedman

by Chris Lancelot

21-May-08 00:00

The economist Milton Friedman made a telling observation: the care with which we spend money depends... Read more

I'm not navigating the cross-referral maze

by Chris Lancelot

14-May-08 00:00

One of the less attractive aspects of the purchaser-provider split is the ham-fisted way in which pr... Read more

'Lord Darzi, you have wrecked UK primary care'

09-May-08 00:00

I was delighted to hear that NHS managers have been taken aback by the strength of feeling against t... Read more

It's time to ignore the prima donnas in the NHS

by Chris Lancelot

30-Apr-08 00:00

Recently I asked who should be in ultimate charge of the NHS, and concluded that it works far more e... Read more

My plea for evidence-based management

by Chris Lancelot

23-Apr-08 00:00

This government is undeniably underhand. Nothing is ever done for the reasons given; hidden agendas ... Read more

Showing 1 - 10 of 91 Articles

Healthcare Republic Forums

 

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week